- Scotland is the first UK nation to implement newborn screening for spinal muscular atrophy.
- A two-year evaluation will determine if early detection improves outcomes for affected infants.
- Campaigners and celebrities are pushing for this heel prick test across the entire United Kingdom.
A pioneering medical initiative has launched in Scotland to identify spinal muscular atrophy in infants. This first-of-its-kind UK screening program integrates testing into the standard heel prick procedure. Approximately 4 days after birth, parents are offered this specific check to detect the rare genetic disorder earlier than ever before.
Spinal muscular atrophy, or SMA, is a condition that leads to progressive muscle wastage and can be fatal. It affects roughly 1 in 14,000 births globally, impacting vital functions like breathing and swallowing. Without swift medical intervention, the life expectancy for those with severe forms may not exceed 2 years.
Early detection via screening is essential because nerve cell damage is irreversible once it begins. When diagnosis only occurs after physical symptoms manifest, treatment options become significantly more restricted. Identifying the condition before symptoms appear ensures that newborns can access transformative medical therapies at the most effective stage possible.
The Scottish government is collaborating with Novartis to fund a 2-year evaluation of this program. Three to four Scottish babies are diagnosed with this condition annually on average. While a permanent cure remains elusive, three specific drug treatments are now provided through the National Health Service to manage the condition.
Advocacy for this testing gained massive momentum following high-profile public campaigns. Former singer Jesy Nelson highlighted the issue after her twins were diagnosed in 2025. Her experience with the grueling diagnostic process led to a petition with over 100,000 signatures, prompting an upcoming debate in the House of Commons.
Health experts believe the data gathered in Scotland will influence national policy. Supporters hope the results will convince the National Screening Committee to adopt the test UK-wide. Since 1 in 40 people carry the gene, universal screening is seen as the best way to give every child a healthy start.
